Reduced forced expiratory volume is associated with increased incidence of atrial fibrillation: The Malmö Preventive Project

Europace

Volumn 16, Issue 2, 2014, Pages 182-188

  Johnson, Linda S B ^a   Juhlin, Tord ^a   Engström, Gunnar ^a   Nilsson, Peter M ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

Atrial fibrillation; Glucose; Hypertension; Lung function; Population; Spirometry

Indexed keywords

GLUCOSE;

ADULT; AIRWAY OBSTRUCTION; ARTICLE; BLOOD SAMPLING; BODY HEIGHT; BODY WEIGHT; CARDIOVASCULAR RISK; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; GENDER; GLUCOSE BLOOD LEVEL; HAZARD RATIO; HEART ATRIUM FIBRILLATION; HIGH RISK POPULATION; HOSPITAL PATIENT; HUMAN; INCIDENCE; LIFESTYLE MODIFICATION; LUNG FUNCTION; LUNG VOLUME; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORBIDITY; MORTALITY; PHYSICAL EXAMINATION; PRIORITY JOURNAL; RISK ASSESSMENT; SEDENTARY LIFESTYLE; SMOKING; SYSTOLIC BLOOD PRESSURE; YOUNG ADULT;

ATRIAL FIBRILLATION; GLUCOSE; HYPERTENSION; LUNG FUNCTION; POPULATION; SPIROMETRY;

ADULT; AGE FACTORS; ATRIAL FIBRILLATION; FEMALE; FOLLOW-UP STUDIES; FORCED EXPIRATORY VOLUME; HUMANS; INCIDENCE; KAPLAN-MEIER ESTIMATE; LUNG; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; SMOKING; SWEDEN; TIME FACTORS; VITAL CAPACITY;

EID: 84893230737     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eut255     Document Type: Article

References (35)

1. Heeringa J, van der Kuip DA, Hofman A, Kors JA, van Herpen G, Stricker BH et al. Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study. Eur Heart J 2006;27:949-53.
2. Benjamin EJ,Wolf PA, D'Agostino RB, Silbershatz H, Kannel WB, Levy D. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation 1998; 98:946-52.
3. Benjamin EJ, Levy D, Vaziri SM, D'Agostino RB, Belanger AJ,Wolf PA. Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA 1994;271:840-4.
4. Huxley RR, Lopez FL, Folsom AR, Agarwal SK, Loehr LR, Soliman EZ et al. Absolute and attributable risks of atrial fibrillation in relation to optimal and borderline risk factors: the Atherosclerosis Risk in Communities (ARIC) study. Circulation 2011; 123:1501-8.
5. Smith JG, Platonov PG, Hedblad B, Engström G., Melander O. Atrial fibrillation in the Malmö Diet and Cancer study: a study of occurrence, risk factors and diagnostic validity. Eur J Epidemiol 2010;25:95-102.
6. Benjamin EJ, Chen PS, Bild DE, Mascette AM, Albert CM, Alonso A et al. Prevention of atrial fibrillation: report from a national heart, lung, and blood instituteworkshop. Circulation 2009;119:606-18.
7. Engström G., Hedblad B, Valind S, Janzon L. Increased incidence of myocardial infarction and stroke in hypertensivemen with reduced lung function. J Hypertens 2001;19: 295-301.
8. Sin DD, Wu L., Man SF. The relationship between reduced lung function and cardiovascular mortality: a population-based study and a systematic review of the literature. Chest 2005;127:1952-9.
9. Söderholm M, Zia E, Hedblad B, Engström G. Lung function as a risk factor for subarachnoid hemorrhage: a prospective cohort study. Stroke 2012;43:2598-603.
10. Engström G., Hedblad B., Janzon L. Reduced lung functionpredicts increased fatality in future cardiac events. A population-based study. J Intern Med 2006;260:560-7.
11. Schroeder EB, Welch VL, Couper D, Nieto FJ, Liao D, Rosamond WD et al. Lung function and incident coronary heart disease: the Atherosclerosis Risk in Communities Study. Am J Epidemiol 2003;158:1171-81.
12. Buch P, Friberg J, Scharling H, Lange P, Prescott E. Reduced lung function and risk of atrial fibrillation in the Copenhagen City Heart Study. Eur Respir J 2003;21:1012-6.
13. de Vos CB, Pisters R, Nieuwlaat R, Prins MH, Tieleman RG, Coelen RJ et al. Progression from paroxysmal to persistent atrial fibrillation clinical correlates and prognosis. J Am Coll Cardiol 2010;55:725-31.
14. Berglund G, Nilsson P, Eriksson KF, Nilsson JA, Hedblad B, Kristenson H et al. Longterm outcome of the Malmö preventive project: mortality and cardiovascular morbidity. J Intern Med 2000;247:19-29.
15. Nilsson PM, Nilsson JA, Berglund G. Population-attributable risk of coronary heart disease risk factors during long-term follow-up: the Malmö Preventive Project. J Intern Med 2006;260:134-41.
16. Trell E. Community-based preventive medical department for individual risk factor assessment and intervention in an urban population. Prev Med 1983;12:397-402.
17. Kristenson H, Trell E. Indicators of alcohol consumption: comparisons between a questionnaire (Mm-MAST), interviews and serum gamma-glutamyl transferase (GGT) in a health survey of middle-aged males. Br J Addict 1982;77:297-304.
18. Ekberg-Aronsson M, Pehrsson K, Nilsson JA, Nilsson PM, Lö fdahl CG. Mortality in GOLD stages of COPD and its dependence on symptoms of chronic bronchitis. Respir Res 2005;6:98.
19. Waldo AL. Inter-relationships between atrial flutter and atrial fibrillation. Pacing Clin Electrophysiol 2003;26:1583-96.
20. Furberg CD, Psaty BM, Manolio TA, Gardin JM, Smith VE, Rautaharju PM. Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study). Am J Cardiol 1994;74:236-41.
21. Shibata Y,Watanabe T, Osaka D, Abe S, Inoue S, Tokairin Y et al. Impairment of pulmonary function is an independent risk factor for atrial fibrillation: the Takahata study. Int J Med Sci 2011;8:514-22.
22. Mehra R, Benjamin EJ, Shahar E, Gottlieb DJ, Nawabit R, Kirchner HL et al. Association of nocturnal arrhythmias with sleep-disordered breathing: the Sleep Heart Health Study. Am J Respir Crit Care Med 2006;173:910-6.
23. Stevenson IH, Roberts-Thomson KC, Kistler PM, Edwards GA, Spence S, Sanders P et al. Atrial electrophysiology is altered by acute hypercapnia but not hypoxemia: implications for promotion of atrial fibrillation in pulmonary disease and sleep apnea. Heart Rhythm 2010;7:1263-70.
24. Mancia G, Bombelli M, Facchetti R, Madotto F, Corrao G, Trevano FQ et al. Longterm prognostic value of blood pressure variability in the general population: results of the Pressioni Arteriose Monitorate e Loro Associazioni Study. Hypertension 2007;49:1265-70.
25. Engström G., Gerhardsson de Verdier M, Dahlbäc K.M., Janson C, Lind L. BP variability and cardiovascular autonomic function in relation to forced expiratory volume: a population-based study. Chest 2009;136:177-83.
26. Maule S, Milan A, Grosso T, Veglio F. Left ventricular hypertrophy in patients with autonomic failure. Am J Hypertens 2006;19:1049-54.
27. Tatasciore A, Renda G, Zimarino M, Soccio M, Bilo G, Parati G et al. Awake systolic blood pressure variability correlates with target-organ damage in hypertensive subjects. Hypertension 2007;50:325-32.
28. Vaziri SM, Larson MG, Benjamin EJ, Levy D. Echocardiographic predictors of nonrheumatic atrial fibrillation. The Framingham Heart Study. Circulation 1994;89: 724-30.
29. Hodgkinson JA, Taylor CJ, Hobbs FD. Predictors of incident atrial fibrillation and influence of medications: a retrospective case-control study. Br J Gen Pract 2011;61: e353-61.
30. Salpeter SR, Ormiston TM, Salpeter EE. Cardiovascular effects of beta-agonists in patients with asthma and COPD: a meta-analysis. Chest 2004;125:2309-21.
31. CaveAC,HurstMM.The use of long acting beta(2)-agonists, alone or in combination with inhaled corticosteroids, in chronic obstructive pulmonary disease (COPD): a risk-benefit analysis. Pharmacol Ther 2011;130:114-43.
32. Hanrahan JP, Grogan DR, Baumgartner RA, Wilson A, Cheng H., Zimetbaum PJ et al. Arrhythmias in patients with chronic obstructive pulmonary disease (COPD): occurrence frequency and the effect of treatment with the inhaled long-acting beta2-agonists arformoterol and salmeterol. Medicine 2008;87:319-28.
33. Engström G, Wollmer P, Valind S, Hedblad B, Janzon L. Blood pressure increase between 55 and 68 years of age is inversely related to lung function: longitudinal results from the cohort study 'Men born in 1914'. J Hypertens 2001;19:1203-8.
34. Engström G, Hedblad B, Nilsson P,Wollmer P, Berglund G, Janzon L. Lung function, insulin resistance and incidence of cardiovascular disease: a longitudinal cohort study. J Intern Med 2003;253:574-81.
35. van der Hooft CS, Heeringa J, Brusselle G.G.,Hofman A, Witteman JC, Kingma JH et al. Corticosteroids and the risk of atrial fibrillation. Arch Intern Med 2006;166:1016-20.